Piet Herdewijn

24.0k total citations · 2 hit papers
787 papers, 19.5k citations indexed

About

Piet Herdewijn is a scholar working on Molecular Biology, Organic Chemistry and Infectious Diseases. According to data from OpenAlex, Piet Herdewijn has authored 787 papers receiving a total of 19.5k indexed citations (citations by other indexed papers that have themselves been cited), including 568 papers in Molecular Biology, 289 papers in Organic Chemistry and 233 papers in Infectious Diseases. Recurrent topics in Piet Herdewijn's work include DNA and Nucleic Acid Chemistry (319 papers), HIV/AIDS drug development and treatment (202 papers) and Advanced biosensing and bioanalysis techniques (154 papers). Piet Herdewijn is often cited by papers focused on DNA and Nucleic Acid Chemistry (319 papers), HIV/AIDS drug development and treatment (202 papers) and Advanced biosensing and bioanalysis techniques (154 papers). Piet Herdewijn collaborates with scholars based in Belgium, United States and France. Piet Herdewijn's co-authors include Erik De Clercq, Arthur Van Aerschot, Jan Balzarini, Rudi Pauwels, Masanori Baba, Jef Rozenski, Jan Desmyter, Robert Snoeck, Roger Busson and Dominique Schols and has published in prestigious journals such as Nature, Science and Chemical Reviews.

In The Last Decade

Piet Herdewijn

765 papers receiving 19.0k citations

Hit Papers

Rapid and automated tetrazolium-based colorimetric assay ... 1988 2026 2000 2013 1988 2012 500 1000 1.5k

Peers

Piet Herdewijn
Alexander Wlodawer United States
Eddy Arnold United States
Ernesto Freire United States
Irene T. Weber United States
Charles S. Craik United States
Daria J. Hazuda United States
Rudi Pauwels Belgium
Hiroaki Mitsuya United States
Alexander Wlodawer United States
Piet Herdewijn
Citations per year, relative to Piet Herdewijn Piet Herdewijn (= 1×) peers Alexander Wlodawer

Countries citing papers authored by Piet Herdewijn

Since Specialization
Citations

This map shows the geographic impact of Piet Herdewijn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Piet Herdewijn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Piet Herdewijn more than expected).

Fields of papers citing papers by Piet Herdewijn

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Piet Herdewijn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Piet Herdewijn. The network helps show where Piet Herdewijn may publish in the future.

Co-authorship network of co-authors of Piet Herdewijn

This figure shows the co-authorship network connecting the top 25 collaborators of Piet Herdewijn. A scholar is included among the top collaborators of Piet Herdewijn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Piet Herdewijn. Piet Herdewijn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Dai, Xing‐Jie, Huimin Liu, Shaopeng Wang, et al.. (2024). Degraders in epigenetic therapy: PROTACs and beyond. Theranostics. 14(4). 1464–1499. 23 indexed citations
2.
Müller, David, M. Edelmann, Puneet Srivastava, et al.. (2024). Rational design of a bacterial import system for new-to-nature molecules. Metabolic Engineering. 85. 26–34. 3 indexed citations
3.
Wang, Yatao, et al.. (2023). Recent advance of clinically approved small-molecule drugs for the treatment of myeloid leukemia. European Journal of Medicinal Chemistry. 261. 115827–115827. 6 indexed citations
4.
Wang, Song, Ying Qu, Haixia Wang, et al.. (2023). Design, synthesis, and anti-respiratory syncytial virus potential of novel 3-(1,2,3-triazol-1-yl)furoxazine-fused benzimidazole derivatives. European Journal of Medicinal Chemistry. 261. 115799–115799. 5 indexed citations
5.
Wang, Mengmeng, Lingyun Li, Piet Herdewijn, et al.. (2023). Synthesis and anti-SARS-CoV-2 evaluation of lipid prodrugs of β-D-N4-hydroxycytidine (NHC) and a 3′-fluoro-substituted analogue of NHC. Bioorganic Chemistry. 135. 106527–106527. 5 indexed citations
6.
Gao, Shenghua, Hongtao Xu, Steven De Jonghe, et al.. (2022). Identification of Polyphenol Derivatives as Novel SARS-CoV-2 and DENV Non-Nucleoside RdRp Inhibitors. Molecules. 28(1). 160–160. 6 indexed citations
7.
Singh, Abhimanyu K., Sergio E. Martinez, Hoai Viet Nguyen, et al.. (2021). Sliding of HIV-1 reverse transcriptase over DNA creates a transient P pocket – targeting P-pocket by fragment screening. Nature Communications. 12(1). 7127–7127. 7 indexed citations
9.
Bande, Omprakash, et al.. (2020). Vitamin-guanosine monophosphate conjugates for in vitro transcription priming. Chemical Communications. 56(18). 2787–2790. 1 indexed citations
10.
Chaput, John C. & Piet Herdewijn. (2019). Was ist XNA?. Angewandte Chemie. 131(34). 11694–11696. 10 indexed citations
11.
Guillaume, Michel, Herman Borghys, L.L. de Zwart, et al.. (2016). Lipophilic nalmefene prodrugs to achieve a one-month sustained release. Journal of Controlled Release. 232. 196–202. 13 indexed citations
12.
Pinheiro, Vitor B., Alexander I. Taylor, Christopher Cozens, et al.. (2012). Synthetic Genetic Polymers Capable of Heredity and Evolution. Science. 336(6079). 341–344. 546 indexed citations breakdown →
13.
Ermolinsky, Boris S., V. L. Tunitskaya, Arthur Van Aerschot, et al.. (2004). Interaction of HIV-1 Reverse Transcriptase with Modified Oligonucleotide Primers Containing 2′-O-β-D-Ribofuranosyladenosine. Biochemistry (Moscow). 69(2). 130–136. 1 indexed citations
14.
Manallack, David T., William R. Pitt, Piet Herdewijn, et al.. (2002). Database Searching for Thymidine and Thymidylate Kinase Inhibitors Using Three-dimensional Structure-based Methods. Journal of Enzyme Inhibition and Medicinal Chemistry. 17(3). 167–174. 5 indexed citations
15.
Herdewijn, Piet. (1999). Conformational and stereochemical analysis as starting point for the design of antiviral compounds. Lirias (KU Leuven). 1 indexed citations
16.
Herdewijn, Piet, Arthur Van Aerschot, Isabelle Duroux-Richard, et al.. (1998). Antisense oligonucleotides as anticancer agents. Lirias (KU Leuven). 1 indexed citations
17.
Pannecouque, Christophe, et al.. (1995). Synthesis and Antiviral Evaluation of 3′-Substituted Thymidine Analogues Derived from 3′-Amino-3′-deoxythymidine. Nucleosides and Nucleotides. 14(3-5). 541–544. 2 indexed citations
18.
Herdewijn, Piet, Jan Balzarini, & Erik De Clercq. (1993). 2',3'-Dideoxynucleoside analogues as anti-HIV agents. Lirias (KU Leuven). 6 indexed citations
19.
Clercq, Erik De, Piet Herdewijn, & H. Vanderhaeghe. (1991). Antibiotics and antiviral agents. Lirias (KU Leuven). 1 indexed citations
20.
Des̀granges, Claude, et al.. (1984). Regeneration of the antiviral drug (E)-5-(2-bromovinyl)-2'-deoxyuridine in vivo.. Lirias (KU Leuven). 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026